• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Republica Press

Your Business & Political News Source

REPUBLICA PRESS
Your Business & Political News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • SCIENCE/TECH
  • US
  • WORLD

Leaders of Emergent, Whose Factory Ruined Vaccines, Will Testify Before House Panel

by

In a statement on Wednesday, the company said that it had responded to the F.D.A.’s observations with a “comprehensive quality enhancement plan” and had “already started making improvements.”

On a recent call with investors, Mr. Kramer announced a management shake-up and took “full responsibility” for the manufacturing problems, acknowledging that the “loss of a batch for a viral contamination is extremely serious, and we treated it as such.” But he also said that Emergent had taken on a “herculean task” in a crisis.

In letters to the two Emergent executives last month, Mr. Clyburn and Representative Carolyn Maloney, Democrat of New York and chairwoman of the House Oversight and Reform Committee, demanded a slew of documents, including any correspondence between the company and Dr. Robert Kadlec, President Trump’s assistant secretary for preparedness and response, who previously consulted for the company. In interviews, Dr. Kadlec has said his consulting work, in 2013 and 2014, was limited and did not affect contracting decisions.

“Emergent has been in the news a lot lately, and that’s frankly not something we’re used to,” Mr. Kramer wrote in a commentary posted on the company’s website last month. “Until a year ago we were a little-known company that does our work behind the scenes.”

The company is trying to burnish its image with television and digital advertising, as part of a campaign it is calling “We Go.” The 30-second ads feature images of white-clad lab technicians and spotlight some of the company’s lesser-known work manufacturing cholera vaccines and medicine used to treat opioid overdoses, as well as its Covid-19 work.

Emergent’s plant in Baltimore is one of two federally designated Centers for Innovation in Advanced Development and Manufacturing, funded in part by taxpayers. In June 2020, the federal government awarded Emergent a $628 million contract, largely to reserve space for coronavirus vaccine manufacturing, despite staffing and quality concerns.

After The Biden administration responded to the potential contamination last month by putting Johnson & Johnson in charge of the Baltimore facility and moving out AstraZeneca. Doses made at the plant have not been cleared for use in the United States, and millions of shots made in Baltimore and sent overseas have also been put on hold.

View Source

Filed Under: US

Primary Sidebar

More to See

$7.45M Hog Island Is the Largest Private Island Available in Florida Right Now

It’s the ultimate in seclusion in the middle of North Central Florida: a private island in the middle of St. Johns River near Lake George.In addition … [Read More...] about $7.45M Hog Island Is the Largest Private Island Available in Florida Right Now

Seattle Seahawks Haven’t Ruled Out Acquiring Baker Mayfield Just Yet

The Seattle Seahawks are very much still in the running for Baker Mayfield. (Photo by Stacy ... [+] Revere/Getty Images) Getty Images The Seattle … [Read More...] about Seattle Seahawks Haven’t Ruled Out Acquiring Baker Mayfield Just Yet

Makgeolli: How Korean rice wine is stepping out of soju’s shadow

(CNN) — Kim Kyung-seop recalls going to cheap bars after class with his friends, where they binged on as much makgeolli as possible. "You know the … [Read More...] about Makgeolli: How Korean rice wine is stepping out of soju’s shadow

Copyright © 2022 · Republica Press · Log in · As an Amazon Associate we earn from qualifying purchases.

Terms and Conditions - Privacy Policy